Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Organ-Procurement Organization and Donor Factor-Related Variation in Deceased Donor Kidney Biopsies and Discards: A National Practice Patterns Analysis
K. Lentine¹, A. Naik², M. Schnitzler¹, H. Randall¹, J. Wellen³, B. Kasiske⁴, G. Marklin⁵, D. Brockmeier⁵, M. Cooper⁶, H. Xiao¹, Z. Zhang¹, R. Gaston⁶, R. Rothweiler⁵, D. Axelrod⁷
¹Saint Louis Univ, St. Louis, MO, ²Univ of Michigan, Ann Arbor, MI, ³Washington Univ, St. Louis, MO, ⁴SRTR, Minneapolis, MN, ⁵Mid-America Transplant, St. Louis, MO, ⁶Georgetown Univ, Washington, DC, ⁷Univ of Iowa, Iowa City, IA
*Purpose: The clinical utility and outcome implications of deceased donor kidney allograft procurement biopsies are controversial.*Methods: We analyzed Scientific Registry of Transplant Recipients data (n=59,328…
2019 American Transplant Congress
Successful Use of Nonantigen Specific Immunoadsorption In ABO-Incompatible Desensitization and Humoral Rejection Treatment in Kidney Transplantation
E. Montagud-Marrahi
Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: : Immunoadsorption (IA) is an apheresis procedure that has been shown to be effective in the ABO incompatible living donor kidney transplantation (ABOi LDKT)…
2019 American Transplant Congress
Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant
P. W. Baron¹, J. Weissman², F. Fazeli³, C. Zuppan⁴, R. Villicana³, P. Wai¹, L. Beeson⁵, M. De Vera¹
¹Surgery/Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ²Pharmacy, Loma Linda University Health, Loma Linda, CA, ³Transplantation Institute, Loma Linda University Health, Loma Linda, CA, ⁴Pathology, Loma Linda University Health, Loma Linda, CA, ⁵Center for Nutrition, Healthy Lifestyle and Disease Prevention/School of Public Health, Loma Linda University Health, Loma Linda, CA
*Purpose: Rabbit anti-thymocyte globulin (rATG) cumulative dose needed to effectively and safely prevent acute cellular rejection is unknown. This study compares the efficacy of total…
2019 American Transplant Congress
Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes
M. Jorgenson¹, J. Descourouez¹, B. Cardinale², B. Lyu³, B. Astor³, N. Garg³, C. Saddler³, J. Smith³, D. Mandelbrot³
¹UW Health, Madison, WI, ²University of Wisconsin-Madison School of Pharmacy, Madison, WI, ³University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI
*Purpose: Cytomegalovirus (CMV) infection in kidney transplant recipients has been anecdotally observed with concomitant or subsequent opportunistic infections (OI), but this association has yet to…
2019 American Transplant Congress
Evolution Of Right Laparoscopic Nephrectomy, Report Of A Tertiary Care Center In Mexico
L. Noriega- Salas, J. Cruz-Santiago, M. Quiñones-Gamero, J. Barcena, M. De Gante, G. Bernaldez-Gomez
Transplant Department, Instituto Mexicano Del Seguro Social, Mexico City, Mexico
*Purpose: Aim: The minimally-invasive approach to donor nephrectomy has been primarily driven for nephrectomy in the living donor; nevertheless, Right Nephrectomy (RN) constitutes a major…
2019 American Transplant Congress
Causes of 30 Day Graft Loss among Shared Kidneys in the National Kidney Registry (NKR)
J. Verbesey¹, A. Thomas², M. Ronin³, D. Segev⁴, A. Waterman⁵, S. Flechner⁶, M. Cooper¹
¹Georgetown University Hospital, Washington, DC, ²University of North Carolina, Chapel Hill, NC, ³National Kidney Registry, New York, NY, ⁴Johns Hopkins University, Baltimore, MD, ⁵UCLA, Los Angeles, CA, ⁶Cleveland Clinic, Cleveland, OH
*Purpose: We have previously reported favorable 1 year graft survival of over 98% in the NKR. Many early concerns associated with organ travel, longer ischemic…
2019 American Transplant Congress
Breakthrough Changes in the Access to Transplantation for the Patients with Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
J. Zuber, M. Frimat, P. Gatault, N. Kamar, L. Couzi, N. Jourde-Chiche, V. Chatelet, S. Caillard, R. Gaisne, D. Bertrand, J. Bamoulid, M. Louis, C. Pouteil-Noble, C. Legendre, M. Peraldi, E. Rondeau, M. Le Quintrec, V. Frémeaux-Bacchi
On behalf of the French aHUS Study Group, France, France
*Purpose: Eculizumab has revolutionized the management of atypical Hemolytic Uremic Syndrome (aHUS). In 2012, the French aHUS Study Group issued recommendations to advocate a pro-transplantation…
2019 American Transplant Congress
Interstitial CD68+ Cells Infiltration and Kidney Graft Outcome
E. Paoletti¹, E. Bussalino², L. Marsano¹, D. Bellino¹, R. Russo¹, A. Parodi¹, G. Garibotto², J. L. Ravetti³
¹Nephrology, Dialysis, and Transplantation, Policlinico San Martino Genova, Genova, Italy, ²Nephrology, Dialysis, and Transplantation, University of Genoa, Genova, Italy, ³Pathology, Policlinico San Martino Genova, Genova, Italy
*Purpose: Macrophage infiltration, as an expression of early inflammation, is associated with unfavorable kidney graft outcome in protocol biopsies. However, few studies have evaluated the…
2019 American Transplant Congress
Attitude towards Organ Donation among Medical Students: Relationship to Knowledge and Beliefs
A. Cerrato, M. Salifu, M. Markell
Nephrology/Medicine, SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Lack of knowledge or misunderstanding of organ donation may underlie physician unwillingness to refer patients for organ donation. We examined baseline knowledge and beliefs…
2019 American Transplant Congress
Kidney Grafts Ultrasound Guided Biopsy Performed By Nephrologist. Regaining Technique And Improving Results
J. Juega, M. Perez, L. Cañas, J. Soler, M. Troya, I. Bancu, R. Lauzurica
Nephrology, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
*Purpose: Stablish the optimal technique and protocol of ultrasound guided renal graft biopsy to be performed by nephrologist compared with previous standard of care, regading…